




Instance: composition-en-774fedb6c66b32bb4aacfa98a373a48f
InstanceOf: CompositionUvEpi
Title: "Composition for cholestagel Package Leaflet"
Description:  "Composition for cholestagel Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/03/268/001-004"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp774fedb6c66b32bb4aacfa98a373a48f)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - cholestagel"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet:</p>
<ol>
<li>What Cholestagel is and what it is used for </li>
<li>What you need to know before you take Cholestagel </li>
<li>How to take Cholestagel </li>
<li>Possible side effects </li>
<li>How to store Cholestagel </li>
<li>Contents of the pack and other information </li>
</ol> </div>"""   
          

* section[=].section[+]
  * title =  "1. What cholestagel is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What cholestagel is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cholestagel contains the active substance colesevelam (as hydrochloride). Taking Cholestagel helps to 
lower the level of cholesterol in your blood. Your doctor should only give you Cholestagel if a diet 
low in fat and cholesterol did not work well enough on its own. </p>
<p>Cholestagel works in your intestinal system by binding bile acids produced by your liver and carrying 
the bile acids out of your body with your faeces. This prevents your body from recycling the bile acids 
from your intestines in the usual way. Without the recycling process, your liver has to make additional 
bile acids. Your liver uses cholesterol from your blood to do this, which lowers the level of cholesterol 
in your blood. </p>
<p>Cholestagel is prescribed to treat a condition known as primary hypercholesterolaemia (when 
cholesterol in the blood is elevated) in adults. 
- Cholestagel may be prescribed on its own in addition to a diet low in fat and cholesterol when 
treatment with a statin (a class of cholesterol-lowering medicines that work in the liver) is 
inappropriate or not well tolerated.<br />
- Cholestagel may be used together with a statin and the diet low in fat and cholesterol when 
patients are not appropriately controlled by the statin on its own.<br />
- Cholestagel may also be used together with ezetimibe (a cholesterol-lowering medicine that works 
by reducing cholesterol absorption from the gut), with or without a statin. </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take cholestagel"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take cholestagel"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Cholestagel:</p>
<ul>
<li>if you are allergic to colesevelam or to any of the other ingredients of this medicine (listed in 
section 6) </li>
<li>if you have a blockage in your intestines or bile ducts (tubes that carry bile) </li>
</ul>
<p>If you are prescribed Cholestagel and any other medicine together you must also read the patient 
information leaflet that comes with that particular medicine before you start to take your medicine.  </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking Cholestagel 
- if your triglyceride levels (a blood fat) are greater than 3.4 mmol/L 
- if you have difficulty in swallowing, or have a major stomach or intestinal disorder 
- if you suffer from constipation, as Cholestagel may induce or worsen this condition. This is 
especially important for patients with coronary heart disease and angina pectoris. </p>
<p>If you think any of these apply to you, you should inform your doctor or pharmacist before taking 
Cholestagel. </p>
<p>Before starting therapy with Cholestagel, your physician should make sure that certain conditions do 
not contribute to your elevated cholesterol levels. These could include poorly controlled diabetes, 
untreated hypothyroidism (low levels of thyroid hormone for which no treatment is being given 
currently), proteins in urine (nephrotic syndrome), altered protein levels in the blood 
(dysproteinaemias), and blockage of the bile transport to your gall bladder (obstructive liver disease). </p>
<p>Children and adolescents 
The safety and efficacy in children (below the age of 18 years) has not been studied. Therefore, 
Cholestagel is not recommended for use in this population. </p>
<p>Other medicines and Cholestagel 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. 
If your doctor suspects that Cholestagel may have an effect on the absorption of the other medication, 
you may be advised to take Cholestagel at least 4 hours before or at least 4 hours after taking the other 
medication. If you need to take other medicines more than once a day, remember that your Cholestagel 
tablets can be taken once a day. </p>
<p>Cholestagel may affect the way in which the following medicines work: 
* Anticoagulant therapy (medicines, such as warfarin, used to thin blood).  If you are taking 
anticoagulant therapy you should consult with your physician to closely monitor 
anticoagulation levels, as Cholestagel may affect the absorption of vitamin K and therefore 
interfere with the activity of warfarin. 
* Thyroid replacement therapy (medicines, such as thyroxine or levothyroxine, used to treat low 
thyroid hormone levels) 
* Oral contraceptives (medicines to prevent pregnancy) 
It is important you take Cholestagel at least 4 hours after you take the oral contraceptive to 
ensure that the effectiveness of the contraceptive is not affected. 
* Verapamil or olmesartan (medicines used to treat high blood pressure). It is important that you 
take olmesartan at least 4 hours before you take Cholestagel. 
* Antidiabetic medications (medicines used to treat diabetes, such as metformin 
extended-release (ER) tablets, glimepiride, glipizide, pioglitazone, repaglinide or glyburide). 
If you are taking medicines for diabetes, you should consult with your physician so that you 
can be closely monitored. It is important that you take glimepiride and glipizide at least 4 
hours before you take Cholestagel. 
* Anti-epileptic medicines (medicines, such as phenytoin, used to treat epilepsy).<br />
<em> Ciclosporin (a medicine used to suppress the immune system).<br />
</em> Ursodeoxycholic acid (a medicine used to dissolve gallstones or treat specific chronic liver 
diseases). 
If you are going to take Cholestagel and one of these medicines, your doctor may want to do tests to 
make sure that Cholestagel does not interfere with these medicines.  </p>
<p>Additionally, if you have any condition that could cause you to have a deficiency of vitamins A, D, E 
or K, your doctor may want to check your vitamin levels periodically while you are taking 
Cholestagel. If necessary, your doctor may advise you to take vitamin supplements. </p>
<p>Pregnancy and breast-feeding 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor or pharmacist for advice before taking this medicine. </p>
<p>If you are prescribed Cholestagel and a statin together it is important that you tell your doctor if you 
are pregnant or if you are planning to become pregnant because statins must not be used during 
pregnancy; the patient information leaflet that comes with that particular statin should be consulted. 
Tell your doctor if you are breast-feeding. Your doctor may stop your medicine. </p>
<p>Driving and using machines 
Your ability to drive or operate machines is not affected by taking Cholestagel tablets. </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take cholestagel"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take cholestagel"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Before starting therapy with Cholestagel, you should be advised to follow a cholesterol-lowering diet 
and you should continue this diet during treatment. </p>
<p>Always take Cholestagel exactly as your doctor or pharmacist has told you. Check with your doctor or 
pharmacist if you are unsure. As described in Section 2, if you will be taking Cholestagel along with 
another medicine it is possible that your doctor will advise you to take Cholestagel at least 4 hours 
before or at least 4 hours after taking the other medicine. 
If you take a medicine called either Neoral  or ciclosporin, please ensure to take it with Cholestagel in 
a consistent pattern over the day; either always together or always separate for a set number of hours. </p>
<p>You should take your Cholestagel tablets with food and liquid. The tablets should be swallowed 
whole. Do not break, crush or chew the tablets. </p>
<p>Combination therapy: 
The recommended dose for Cholestagel, when used with a statin or ezetimibe or both together, is 4 to 
6 tablets a day by mouth. Your doctor may tell you to take the Cholestagel dose either once a day or 
twice a day; in either case Cholestagel should be taken with a meal. The dosing of the statin and the 
ezetimibe should follow the instructions for that particular medicine. The medicines may be taken at 
the same time or at separate times according to what your doctor has prescribed. </p>
<p>Monotherapy: 
The recommended dose for Cholestagel is 3 tablets taken twice a day with meals or 6 tablets a day 
with a meal. Your doctor may increase your dose to 7 tablets per day. </p>
<p>If you take more Cholestagel than you should 
Please contact your doctor. Constipation or bloating could occur. </p>
<p>If you forget to take Cholestagel 
You may take your dose with a later meal, but never take in one day more than the total number of 
tablets that your doctor has prescribed to you in a single day. </p>
<p>If you stop taking Cholestagel 
Your cholesterol may increase to the level it was before treatment was started. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>The following side effects have been reported in patients taking Cholestagel:<br />
Very common (may affect more than 1 in 10 people): flatulence (wind), constipation. 
Common (may affect up to 1 in 10 people): vomiting, diarrhoea, indigestion, abdominal pain, 
abnormal stools, feeling sick, bloating, headache, raised levels of triglycerides (fats) in your blood. 
Uncommon (may affect up to 1 in 100 people): muscle pain, raised levels of liver enzymes in your 
blood, difficulty in swallowing. 
Very rare (may affect up to 1 in 10,000 people): inflammation of the pancreas. 
Not known (frequency cannot be estimated from the available data): blockage of the intestines (which 
can increase among patients with a history of blockage of the intestines or intestinal removal). </p>
<p>Reporting of side effects<br />
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. How to store cholestagel"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store cholestagel"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and bottle label after 
 EXP  </p>
<p>Keep the bottle tightly closed in order to protect from moisture. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help to protect the environment. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Cholestagel contains </p>
<ul>
<li>
<p>The active substance is colesevelam (as hydrochloride). Each tablet contains 625 mg 
colesevelam. </p>
</li>
<li>
<p>The other ingredients (excipients) are: 
Tablet core: 
Microcrystalline cellulose (E460) 
Silica colloidal anhydrous 
Magnesium stearate 
Purified water </p>
</li>
</ul>
<p>Film-coating: 
Hypromellose (E464) 
Diacetylated monoglycerides </p>
<p>Printing ink: 
Iron oxide black (E172) 
Hypromellose (E464) 
Propylene glycol </p>
<p>What Cholestagel looks like and contents of the pack </p>
<p>Cholestagel tablets are off-white, capsule-shaped film-coated tablets and imprinted with  C625  on 
one side. The tablets are packed in plastic bottles with child resistant closures. Pack sizes are 
24 (1 x 24), 100 (2 x 50) and 180 (1 x 180) tablets. Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder and Manufacturer </p>
<p>Marketing authorisation holder 
CHEPLAPHARM Arzneimittel GmbH 
Ziegelhof 17489 Greifswald 
Germany  </p>
<p>Manufacturer 
Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland </p>
<p>This leaflet was last revised in  </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p> </div>"""      



Instance: composition-da-774fedb6c66b32bb4aacfa98a373a48f
InstanceOf: CompositionUvEpi
Title: "Composition for cholestagel Package Leaflet"
Description:  "Composition for cholestagel Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/03/268/001-004"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp774fedb6c66b32bb4aacfa98a373a48f)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - cholestagel"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. INDLÆGSSEDDEL"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. INDLÆGSSEDDEL"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Indlægsseddel: Information til brugeren"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Indlægsseddel: Information til brugeren"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "Oversigt over indlægssedlen"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Oversigt over indlægssedlen"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse 
2. Det skal De vide, før De begynder at tage Cholestagel 
3. Sådan skal De tage Cholestagel 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p> </div>"""   
          

* section[=].section[+]
  * title =  "1. Virkning og anvendelse"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. Virkning og anvendelse"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cholestagel indeholder det aktive stof colesevelam (som hydrochlorid). Cholestagel er med til at 
sænke kolesterolindholdet i Deres blod. Deres læge bør kun give Dem Cholestagel, hvis en fedt- og 
kolesterolfattig kost alene ikke virkede godt nok.  </p>
<p>Cholestagel virker i Deres tarmsystem ved at binde galdesyrer, som leveren producerer, og føre 
galdesyrerne ud af kroppen med afføringen. Dette forhindrer kroppen i at recirkulere galdesyrerne fra 
tarmene, som det normalt sker. Uden denne recirkulation skal leveren fremstille yderligere galdesyrer. 
Deres lever bruger kolesterol fra blodet til dette, hvilket sænker kolesterolindholdet i Deres blod.  </p>
<p>Cholestagel ordineres til behandling af en tilstand, der kaldes primær hyperkolesterolæmi (når 
kolesteroltallet i blodet er for højt) hos voksne.<br />
- Cholestagel kan ordineres alene sammen med en diæt, der er fedt- og kolesterolfattig, når 
behandling med et statin (en type kolesterolsænkende medicin, der virker i leveren) er 
uhensigtsmæssigt eller ikke tåles godt.<br />
- Cholestagel kan anvendes sammen med et statin og den fedt- og kolesterolfattige diæt, når 
patienterne ikke behandles hensigtsmæssigt med statin alene. Medens De tager Cholestagel, skal 
de også følge en kolesterolsænkende diæt.<br />
- Cholestagel kan også − med eller uden statin − anvendes sammen med ezetimib (et 
kolesterolsænkende lægemiddel, der virker ved at nedsætte optagelsen af kolesterol fra tarmen). </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. Det skal du vide, før du begynder at tage  cholestagel"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. Det skal du vide, før du begynder at tage  cholestagel"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Cholestagel:</p>
<ul>
<li>hvis De er allergisk over for colesevelam eller et af de øvrige indholdsstoffer i Cholestagel 
(angivet i punkt 6) </li>
<li>hvis De har en blokering i tarmene eller galdegangene </li>
</ul>
<p>Hvis De får ordineret Cholestagel og anden medicin sammen, skal De også læse den indlægsseddel, 
der følger med den pågældende medicin, før De begynder at tage medicinen.  </p>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen eller apotekspersonalet, før De tager Cholestagel 
- hvis Deres triglyceridniveauer (et fedtstof i blodet) er større end 3,4 mmol/l 
- hvis De har problemer med at synke eller har en alvorlig mave- eller tarmsygdom 
- hvis De lider af forstoppelse, da Cholestagel kan fremkalde eller forværre denne tilstand. Dette er 
især vigtigt for patienter med koronar hjertesygdom og angina pectoris. </p>
<p>Hvis De mener, at én af disse to betingelser gælder for Dem, skal De underrette Deres læge eller 
apotek, før De begynder at tage Cholestagel. </p>
<p>Før De påbegynder behandlingen med Cholestagel, skal Deres læge sikre, at visse tilstande ikke 
bidrager til Deres forhøjede kolesteroltal. Der kan være tale om dårligt kontrolleret diabetes, 
ubehandlet hypothyroidea (lavt niveau for thyroidhormon, som der ikke aktuelt gives nogen 
behandling for), protein i urinen (nefrotisk syndrom), ændret proteinniveau i blodet (dysproteinæmi) 
og blokering af transporten af galde til galdeblæren (obstruktiv leversygdom).  </p>
<p>Børn og unge<br />
Sikkerheden og virkningen hos børn (under 18 år) er ikke blevet undersøgt. Cholestagel anbefales 
derfor ikke til brug til denne aldersgruppe. </p>
<p>Brug af anden medicin sammen med Cholestagel 
Fortæl det altid til lægen eller apotekspersonalet, hvis De tager anden medicin eller har gjort det for 
nylig. 
Hvis Deres læge har en mistanke om, at Cholestagel kan påvirke optagelsen af det andet lægemiddel, 
vil De måske blive rådet til at tage Cholestagel mindst 4 timer før eller mindst 4 timer efter, at De har 
taget det andet lægemiddel. Hvis De skal tage anden medicin mere end én gang om dagen, skal De 
huske, at De kan tage Deres Cholestagel-tabletter én gang om dagen. </p>
<p>Cholestagel kan påvirke den måde, som følgende lægemidler virker på: </p>
<ul>
<li>
<p>Koagulationshæmmende behandling (lægemidler som warfarin, der anvendes til at fortynde 
blodet). Hvis De er i behandling med blodfortyndende medicin, skal De kontakte Deres læge 
med henblik på at kontrollere blodets koagulation. Cholestagel kan påvirke optagelsen af 
vitamin K og derfor også aktiviteten af warfarin.  </p>
</li>
<li>
<p>Thyroidea-erstatningsterapi (lægemidler, f.eks. thyroxin eller levothyroxin, der anvendes til at 
behandle lave niveauer af skjoldbruskkirtelhormon). </p>
</li>
<li>
<p>Oral prævention (lægemidler til forebyggelse af graviditet). Det er vigtigt, at De tager 
Cholestagel mindst 4 timer efter orale præventionsmidler for at sikre, at den 
svangerskabsforebyggende virkning ikke påvirkes. </p>
</li>
<li>
<p>Verapamil eller olmesartan (lægemidler, der anvendes til behandling af for højt blodtryk). Det 
er vigtigt, at De tager olmesartan mindst 4 timer inden, De tager Cholestagel. </p>
</li>
<li>
<p>Antidiabetika (medicin, der anvendes til behandling af sukkersyge, såsom metformin 
depottabletter, glimepirid, glipzid, pioglitazon, repaglinid eller glibenclamid). Hvis De tager 
diabetesmedicin, skal De spørge Deres læge til råds, så De kan blive nøje overvåget. Det er 
vigtigt, at De tager glimepirid og glipizid mindst 4 timer inden, De tager Cholestagel. </p>
</li>
<li>
<p>Antiepileptika (medicin såsom phenytoin, der anvendes til behandling af epilepsi). </p>
</li>
<li>
<p>Ciclosporin (et lægemiddel, der bruges til undertrykkelse af immunsystemet).  </p>
</li>
<li>
<p>Ursodeoxycholsyre (medicin, der bruges til at opløse galdesten eller behandle specifikke 
kroniske leversygdomme).  </p>
</li>
</ul>
<p>Hvis De skal tage Cholestagel og ét af disse lægemidler samtidig, vil Deres læge måske ønske at tage 
prøver for at sikre, at Cholestagel ikke påvirker den måde, hvorpå disse lægemidler virker.  </p>
<p>Desuden gælder det, at hvis De har en sygdom, der eventuelt kan medføre mangel på vitamin A, D, E 
eller K, vil Deres læge måske ønske at kontrollere Deres vitaminniveau jævnligt, medens De tager 
Cholestagel. Om nødvendigt kan Deres læge råde Dem til at tage vitamintilskud. </p>
<p>Graviditet og amning 
Hvis De er gravid eller ammer, har mistanke om, at De er gravid, eller planlægger at blive gravid, skal 
De spørge Deres læge eller apotekspersonalet til råds, før De tager dette lægemiddel. </p>
<p>Hvis De får ordineret Cholestagel og et statin sammen, er det vigtigt, at De fortæller Deres læge det, 
hvis De er gravid, eller hvis De planlægger at blive gravid, idet statiner ikke må anvendes under 
graviditet; der henvises til den indlægsseddel, der følger med det pågældende statin. 
Fortæl Deres læge det, hvis De ammer. Deres læge vil måske afbryde Deres medicinering. </p>
<p>Trafik- og arbejdssikkerhed 
Deres evne til at køre bil og betjene maskiner påvirkes ikke af, at De tager Cholestagel tabletter. </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. Sådan skal du tage cholestagel"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. Sådan skal du tage cholestagel"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Før De starter på behandling med Cholestagel, skal De have besked om at følge en kolesterolsænkende 
diæt, og De skal fortsætte med denne diæt under behandlingen. </p>
<p>Tag altid lægemidlet nøjagtigt efter lægens eller apotekspersonalets anvisning. Er De i tvivl, så spørg 
lægen eller apotekspersonalet. Hvis De tager andre lægemidler sammen med Cholestagel, er det 
muligt, at Deres læge − som beskrevet i punkt 2 − vil råde Dem til at tage Cholestagel mindst 4 timer 
før eller mindst 4 timer efter, at De har taget de andre lægemidler. 
Hvis De tager medicin med navnet Sandimmun Neoral® eller ciclosporin, skal De sørge for at tage det 
i et ensartet mønster sammen med Cholestagel, enten altid sammen eller adskilt af det samme antal 
timer. </p>
<p>De skal tage Cholestagel sammen med mad og væske. Tabletterne skal synkes hele. Tabletterne må 
ikke deles, knuses eller tygges. </p>
<p>Kombinationsbehandling 
Den anbefalede dosis af Cholestagel, når det bruges sammen med et statin eller ezetimib eller begge 
samtidig, er 4 til 6 tabletter gennem munden pr. dag. Deres læge vil muligvis bede Dem om at tage 
Deres dosis af Cholestagel enten én gang om dagen eller to gange om dagen. I begge tilfælde skal 
Cholestagel tages sammen med et måltid. Doseringen af statinet og ezetimib skal følge anvisningerne 
for det pågældende lægemiddel. De lægemidler kan tages samtidig eller hver for sig, afhængig af 
lægens ordination.  </p>
<p>Enkeltstofbehandling 
Den anbefalede dosis for Cholestagel er 3 tabletter to gange om dagen sammen med et måltid eller 6 
tabletter om dagen sammen med et måltid. Deres læge kan eventuelt øge dosis til 7 tabletter om dagen.  </p>
<p>Hvis De har taget for meget Cholestagel 
Kontakt Deres læge. Forstoppelse eller oppustethed kan forekomme. </p>
<p>Hvis De har glemt at tage Cholestagel 
De kan tage Deres dosis sammen med et senere måltid, men De må aldrig på én dag tage mere end det 
samlede antal tabletter, som Deres læge har ordineret til Dem.  </p>
<p>Hvis De holder op med at tage Cholestagel 
Deres kolesteroltal kan stige til det niveau, det lå på før behandlingens start.  </p>
<p>Spørg lægen eller apotekspersonalet, hvis der er noget, De er i tvivl om. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Bivirkninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Bivirkninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Følgende bivirkninger er indberettet fra patienter, der har fået Cholestagel:<br />
Meget almindelig (kan forekomme hos flere end 1 ud af 10 personer): flatulens (luft i maven), 
forstoppelse. 
Almindelig (kan forekomme hos op til 1 ud af 10 personer): opkastning, diarré, fordøjelsesbesvær, 
mavesmerter, unormal afføring, kvalme, oppustethed, hovedpine, forhøjede niveauer af triglycerider 
(fedtstoffer) i blodet. 
Ikke almindelig (kan forekomme hos op til 1 ud af 100 personer): muskelsmerter, forhøjede niveauer 
af leverenzymer i blodet, synkebesvær. 
Meget sjælden (kan forekomme hos op til 1 ud af 10.000 personer): betændelse i bugspytkirtlen. 
Ikke kendt (kan ikke vurderes ud fra forhåndenværende data): blokeret tarm (tarmslyng - som kan 
være hyppigere hos patienter, som tidligere har haft tarmslyng eller har fået dele af tarmen fjernet). </p>
<p>Indberetning af bivirkninger 
Hvis De oplever bivirkninger, bør De tale med Deres læge, sygeplejerske eller apoteket. Dette gælder 
også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. De eller Deres pårørende kan 
også indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem 
anført i Appendiks V. Ved at indrapportere bivirkninger kan De hjælpe med at fremskaffe mere 
information om sikkerheden af dette lægemiddel. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. Opbevaring"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. Opbevaring"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn.  </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på pakningen efter “EXP". </p>
<p>Hold tabletbeholderen tæt tillukket for at beskytte mod fugt. </p>
<p>Spørg på apoteket, hvordan De skal bortskaffe medicinrester. Af hensyn til miljøet må De ikke smide 
medicinrester i afløbet, toilettet eller skraldespanden. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Pakningsstørrelser og yderligere oplysninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Pakningsstørrelser og yderligere oplysninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cholestagel indeholder:</p>
<ul>
<li>
<p>Aktivt stof: colesevelam (som hydrochlorid). Hver tablet indeholder 625 mg colesevelam.  </p>
</li>
<li>
<p>Øvrige indholdsstoffer (hjælpestoffer):<br />
Tabletkerne: 
mikrokrystallinsk cellulose (E460) 
silica, kolloid vandfri<br />
magnesiumstearat 
renset vand </p>
</li>
</ul>
<p>Filmovertræk: 
hypromellose (E464) 
diacetylerede monoglycerider </p>
<p>Tryk: 
jernoxid, sort (E172) 
hypromellose (E464) 
propylenglycol </p>
<p>Udseende og pakningsstørrelser 
Cholestagel tabletter er offwhite, kapselformede, filmovertrukne tabletter med ‘C625’ påtrykt på den 
ene side. Tabletterne er emballeret i plastbeholder med børnesikret lukning. Pakningsstørrelserne er 
24 (1 x 24), 100 (2 x 50) og 180 (1 x 180) tabletter. Ikke alle pakningsstørrelser er nødvendigvis 
markedsført. </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller 
Indehaver af markedsføringstilladelsen 
CHEPLAPHARM Arzneimittel GmbH 
Ziegelhof 17489 Greifswald 
Tyskland  </p>
<p>Fremstiller 
Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Irland </p>
<p>Denne indlægsseddel blev senest ændret </p>
<p>Andre informationskilder </p>
<p>De kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu/. </p> </div>"""      





                    
Instance: bundlepackageleaflet-en-774fedb6c66b32bb4aacfa98a373a48f
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for cholestagel Package Leaflet for language en"
Description: "ePI document Bundle for cholestagel Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-774fedb6c66b32bb4aacfa98a373a48f"
* entry[0].resource = composition-en-774fedb6c66b32bb4aacfa98a373a48f

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp774fedb6c66b32bb4aacfa98a373a48f"
* entry[=].resource = mp774fedb6c66b32bb4aacfa98a373a48f
                            
                    
Instance: bundlepackageleaflet-da-774fedb6c66b32bb4aacfa98a373a48f
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for cholestagel Package Leaflet for language da"
Description: "ePI document Bundle for cholestagel Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-774fedb6c66b32bb4aacfa98a373a48f"
* entry[0].resource = composition-da-774fedb6c66b32bb4aacfa98a373a48f

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp774fedb6c66b32bb4aacfa98a373a48f"
* entry[=].resource = mp774fedb6c66b32bb4aacfa98a373a48f
                            
                    



Instance: mp774fedb6c66b32bb4aacfa98a373a48f
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Cholestagel 625 mg film-coated tablets"
Description: "Cholestagel 625 mg film-coated tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/03/268/001-004"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Cholestagel 625 mg film-coated tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 774fedb6c66b32bb4aacfa98a373a48fListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "cholestagel"

* status = #current
* mode = #working

* title = "List of all ePIs associated with cholestagel"

* subject = Reference(mp774fedb6c66b32bb4aacfa98a373a48f)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#cholestagel "cholestagel"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-774fedb6c66b32bb4aacfa98a373a48f) // cholestagel en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-774fedb6c66b32bb4aacfa98a373a48f) // cholestagel da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-774fedb6c66b32bb4aacfa98a373a48f
InstanceOf: List

* insert 774fedb6c66b32bb4aacfa98a373a48fListRuleset
    